hashimoto's disease and glp 1 The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care GLP-1 medications and thyroid disease

Early results indicate about 10-25% of users experience minimal weight loss or even slight weight gain

Initial management included nasogastric decompression, intravenous fluids, bowel rest, and pain control

This approach may inadvertently harm patients who show minimal early response to lifestyle modifications alone

For these reasons, GLP-1 microdosing should only be considered under the supervision of a licensed healthcare provider who can guide dosing decisions and monitor safety over time

Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

Your cardiologist or primary care physician can connect you to our colleagues in endocrinology, bariatric medicine, and other specialties